Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Royal College of Surgeons in Ireland - Medical University of Bahrain
single centre randomised control trial with the aim of comparing the superiority of effectiveness and safety of fluticasone-vilanterol versus usual care. In this study there is random allocation of participants to usual care (Any ICS or SABA combination) or fluticasone-vilanterol daily single dose for the relief of symptoms.
Age
21–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adults between the ages of 18 and 75 years old with a diagnosis of mild asthma attending the participating primary health care centres in Bahrain, being managed with usual care (SABA or ICS and SABA combination) and no other medications
You may not be if
Health centre medical record or self-reported use of LABA, leukotriene receptor agonist, theophylline, anticholinergic agent, oral corticosteroids for regular maintenance therapy in 3 months before entry to the trial. \[NB. nasal corticosteroid is permitted
Clareo Health | Fluticasone-Vilanterol Once Daily Dose for the Treatment of Mild Asthma in Adults
